Stockreport

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies t [Read more]